Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2012
11/29/2012WO2012159959A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012WO2012159457A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
11/29/2012US20120302755 Imaging Agents for Detecting Neurological Dysfunction
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302598 Imidazopyridinones
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012US20120302596 Azaindoles having serotonin receptor affinity
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302560 Novel Benzoic Pyrrolopyridine Derivatives
11/29/2012US20120302548 2-arylimidazole derivatives as pde10a enzyme inhibitors
11/29/2012US20120302540 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
11/29/2012US20120302538 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
11/29/2012US20120302533 Derivatives of pyrimido [6,1-a] isoquinolin-4-one
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120298975 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/29/2012US20120298969 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
11/29/2012CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof
11/29/2012CA2836872A1 Novel compound having affinity for amyloid
11/29/2012CA2836084A1 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
11/29/2012CA2835722A1 Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same
11/29/2012CA2833203A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/29/2012CA2833192A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/29/2012CA2827708A1 Solid forms of a pharmaceutically active substance
11/28/2012EP2527344A1 Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2527343A1 Heterocyclic compound having azole group
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2527007A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/28/2012EP2526945A1 New CRTH2 Antagonists
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012EP2526090A2 New anti-malarial agents
11/28/2012CN102803262A Novel sterically hindered amine light stabilizers
11/28/2012CN102803261A Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/28/2012CN102803260A Substituted polycyclic carbamoylpyridone derivative
11/28/2012CN102803259A 1H-Imidazo[4, 5-c]quinolinone compounds, useful for the treatment of proliferative diseases
11/28/2012CN102803246A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803223A Cyclic compound having substituted phenyl group
11/28/2012CN102796166A Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof
11/28/2012CN102796133A Rare-earth europium complex and application thereof as luminescence material
11/28/2012CN102796124A Di-beta-carboline alkali compound and preparation method, medicinal composition and application thereof
11/28/2012CN102796101A Synthesis method for 2,3,8,9-tetrahydropyridino[2,3-d:6,5-d']dipyrimidine-4,6(1H,7H)-diketone
11/28/2012CN102796100A Substituted phenyl-(diazaspiro-N)-ketone derivative
11/28/2012CN102796099A Imidazoquinolines as lipid kinase inhibitors
11/28/2012CN102796098A (1S, 3S)-1-1, 3-benzodioxole-1, 2, 3, 4-tetrahydrophthalic anhydride-beta-carboline-3-formyl-amino acid methyl ester, and preparation method and application thereof
11/28/2012CN102796097A Phenanthroindolizidine alkaloid derivative, and preparation method, medical composition and application thereof
11/28/2012CN102796041A Quinoline thiourea compound, and synthesis method and application thereof
11/28/2012CN102150670B Application of phenanthroindolizidine and phenanthroquinolizidine derivatives and salts thereof in pesticides
11/28/2012CN102093366B Bicyclo-amino pyrazol compound and application of bicycle-amino pyrazol compound in resisting coxsackie virus
11/28/2012CN101903382B Heterocyclic antiviral compounds
11/28/2012CN101768161B Nitrogen-containing heterocyclic compound with pesticidal activity, preparation and application thereof
11/28/2012CN101717397B Substituted pyridino-[2',1':2,3] imidazo[4,5-c] isoquinolone compounds, method for synthesizing same, use of same and medicinal composition having same
11/28/2012CN101684119B 5,8-disubstituted-1,6-quinazoline-7-amidocarbonylation compound, preparing method, composite and application thereof
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101437822B Compounds and compositions as protein kinase inhibitors
11/28/2012CN101432278B Diketo-piperazine and piperidine derivatives as antiviral agents
11/28/2012CN101151265B Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
11/27/2012US8318944 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/27/2012US8318940 Naphthyridin-2 (1 H)-one compounds useful as antibacterials
11/27/2012US8318939 Kinase inhibitors
11/27/2012US8318938 Trans-fused chromenoisoquinolines synthesis and methods for use
11/27/2012US8318931 Chemokine receptor antagonists and use thereof
11/27/2012US8318767 Substituted imidazoles as bombesin receptor subtype-3 modulators
11/27/2012US8318751 Pyrimidinone derivatives and methods of use thereof
11/27/2012US8318732 Compounds having antiviral properties
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318720 Acrylamide derivatives as Fab I inhibitors
11/27/2012US8318718 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11/27/2012CA2706571C 5-anilinoimidazopyridines and methods of use
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses
11/27/2012CA2561944C Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012158810A1 Tyrosine kinase inhibitors
11/22/2012WO2012158658A1 Fused bicyclic kinase inhibitors
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012157744A1 1-THIOXO-1,2,3,4-TETRAHYDRO-β-CARBOLINE DERIVATIVE AND ANTI-CANCER AGENT COMPRISING SAME
11/22/2012WO2012156339A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120296089 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295931 Spiroindoline compounds for use as anthelminthics
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295901 Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295883 Compounds
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
11/22/2012US20120292603 Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device
11/22/2012US20120292576 Compounds for electronic devices
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2834077A1 Inhibitors of bruton's tyrosine kinase
11/22/2012CA2832334A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/21/2012EP2524917A1 Fused pyridine derivatives
11/21/2012EP2524915A1 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 646